Progress and prospects of biomarkers in primary liver cancer

YX Gao, TW Yang, JM Yin… - International …, 2020 - spandidos-publications.com
Tumor biomarkers are important in the early screening, diagnosis, therapeutic evaluation,
recurrence and prognosis prediction of tumors. Primary liver cancer is one of the most …

N6-Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis

F Chen, Z Chen, T Guan, Y Zhou, L Ge, H Zhang, Y Wu… - Cancer research, 2021 - AACR
The roles of RNA modification during organ metastasis of cancer cells are not known. Here
we established breast cancer lung metastasis cells by three rounds of selection of lung …

Liver Organoids as an in vitro model to study primary liver cancer

S De Siervi, C Turato - International Journal of Molecular Sciences, 2023 - mdpi.com
Primary liver cancers (PLC), including hepatocellular carcinoma (HCC) and
cholangiocarcinoma (CCA), are among the leading causes of cancer-related mortality …

Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells

S Thongchot, A Ferraresi, C Vidoni, W Loilome… - Cancer letters, 2018 - Elsevier
Cholangiocarcinoma (CCA), the cancer arising from the epithelial cells of bile ducts, is a
prototype of inflammatory-driven cancer. Cytokines released by cancer associated …

[HTML][HTML] Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors

A Menz, R Bauer, M Kluth, CM von Bargen… - Human Pathology, 2021 - Elsevier
Summary To evaluate cytokeratin 19 (CK19) expression in normal and cancerous tissues,
15,977 samples from 122 tumor types and 608 samples of 76 normal tissue types were …

Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis

X Huang, L Long, J Wei, Y Li, Y Xia, P Zuo… - Journal of cancer …, 2019 - Springer
Purpose To describe the clinical characteristics and outcomes of patients with dual-
phenotype hepatocellular carcinoma (DPHCC) and investigate the use of radiomics to …

PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome

L Tian, J Ma, L Ma, B Zheng, L Liu, D Song… - World journal of surgical …, 2020 - Springer
Objective Immunotherapy targeting the programmed cell death protein-1 (PD-
1)/programmed cell death protein ligand 1 (PD-L1) pathway has been observed to be …

Preoperative ultrasound radiomics signatures for noninvasive evaluation of biological characteristics of intrahepatic cholangiocarcinoma

Y Peng, C Zhou, P Lin, D Wen, X Wang, X Zhong… - Academic radiology, 2020 - Elsevier
Rationale and Objectives The purpose of this study was to establish and validate radiomics
signatures based on ultrasound (US) medicine images to assess the biological behaviors of …

Preoperative Diagnosis of Dual‐Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models

Q Wu, Y Yu, T Zhang, W Zhu, Y Fan… - Journal of Magnetic …, 2023 - Wiley Online Library
Background Dual‐phenotype hepatocellular carcinoma (DPHCC) is highly aggressive and
difficult to distinguish from hepatocellular carcinoma (HCC). Purpose To develop and …

The role of immunohistochemistry in the differential diagnosis between intrahepatic cholangiocarcinoma, hepatocellular carcinoma and liver metastasis, as well as its …

LP Mocan, I Rusu, CS Melincovici, BA Boșca, T Mocan… - Diagnostics, 2023 - mdpi.com
Intrahepatic cholangiocarcinoma (iCCA) is the second most frequent primary hepatic
malignant tumor, after hepatocellular carcinoma (HCC). Its incidence has risen worldwide …